|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 |
| (11) | Patento numeris | 1748766 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05740148.1 |
| Europos patento paraiškos padavimo data | 2005-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-06-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/014021 |
| Data | 2005-04-21 |
| (87) | Numeris | WO 2005/110380 |
| Data | 2005-11-24 |
| (30) | Numeris | Data | Šalis |
| 836880 | 2004-04-30 | US |
| (72) |
HUANG, Glenn, T., US
NIVAGGIOLI, Thierry, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED RELEASE INTRAOCULAR IMPLANTS COMPRISING A BETA ADRENERGIC RECEPTOR ANTAGONIST AND METHODS FOR TREATING OCULAR NEUROPATHIES |
| SUSTAINED RELEASE INTRAOCULAR IMPLANTS COMPRISING A BETA ADRENERGIC RECEPTOR ANTAGONIST AND METHODS FOR TREATING OCULAR NEUROPATHIES |